BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 15665153)

  • 1. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life.
    Harpin VA
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i2-7. PubMed ID: 15665153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.
    Barkley RA
    Postgrad Med; 2008 Sep; 120(3):48-59. PubMed ID: 18824825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADHD affects not only children, but also adults.
    Waldman HB; Perlman SP; Chaudhry RA
    J N J Dent Assoc; 2009; 80(1):25-8. PubMed ID: 19441183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of attention-deficit/hyperactivity disorder in adults.
    Goodman DW
    J Psychiatr Pract; 2007 Sep; 13(5):318-27. PubMed ID: 17890980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviour problems and social competence deficits associated with symptoms of attention-deficit/hyperactivity disorder: effects of age and gender.
    Thorell LB; Rydell AM
    Child Care Health Dev; 2008 Sep; 34(5):584-95. PubMed ID: 18796051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC; Schoemaker MM
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care treatment of attention-deficit/hyperactivity disorder.
    Culpepper L
    J Clin Psychiatry; 2006; 67 Suppl 8():51-8. PubMed ID: 16961431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder in adult life.
    Silver LB
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):511-23. PubMed ID: 10944654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ADHD with amphetamine: short-term effects on family interaction.
    Gustafsson P; Hansson K; Eidevall L; Thernlund G; Svedin CG
    J Atten Disord; 2008 Jul; 12(1):83-91. PubMed ID: 17968029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
    Adler LA; Sutton VK; Moore RJ; Dietrich AP; Reimherr FW; Sangal RB; Saylor KE; Secnik K; Kelsey DK; Allen AJ
    J Clin Psychopharmacol; 2006 Dec; 26(6):648-52. PubMed ID: 17110824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of children with attention-deficit/hyper activity disorder.
    Pongwilairat K; Louthrenoo O; Charnsil C; Witoonchart C
    J Med Assoc Thai; 2005 Aug; 88(8):1062-6. PubMed ID: 16404833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 20. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.